Ernexa Therapeutics Inc. Gain (Loss) on Termination of Lease
Ernexa Therapeutics Inc. (ERNA) reported Gain (Loss) on Termination of Lease of $56.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-06
- Ernexa Therapeutics Inc. gain (loss) on termination of lease for the quarter ending 2026-03-31 was $56.00K.
- Ernexa Therapeutics Inc. gain (loss) on termination of lease for the quarter ending 2024-09-30 was $1.58M.
- Ernexa Therapeutics Inc. gain (loss) on termination of lease for fiscal 2024 was $1.58M.
- Ernexa Therapeutics Inc. gain (loss) on termination of lease for fiscal 2020 was -$9.00K.
| Period end | Gain (Loss) on Termination of Lease | Gain (Loss) on Termination of Lease 0 month | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56.00K 10-Q · filed 2026-08-06 | |||||
| 2026-03-31 | $56.00K 10-Q · filed 2026-05-11 | |||||
| 2026-02-16 | $56.00K 10-Q · filed 2026-08-06 | |||||
| 2024-12-31 | $1.58M 10-K · filed 2026-03-13 | |||||
| 2024-09-30 | $1.58M 10-Q · filed 2025-11-07 | $1.58M 10-Q · filed 2025-11-07 | ||||
| 2020-12-31 | -$9.00K 10-K · filed 2021-03-11 | |||||
| 2020-09-30 | -$9.00K 10-Q · filed 2020-11-13 | |||||
| 2020-06-30 | $200.00K 10-K · filed 2021-03-11 | $8.00K 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |